PTN. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial Top-line Data Expected First-Half Next Quarter http://finance.yahoo.com/news/palatin-technologies-announces-last-patient-113000330.html stockcharts.com/c-sc/sc?s=PTN&p=D&yr=0&mn=3&dy=0&i=t83492109650&r=1347277584825